DVLA logo

PT Darya-Varia Laboratoria Tbk Stock Price

IDX:DVLA Community·Rp1.8t Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

DVLA Share Price Performance

Rp0
-1685.00 (-100.00%)
Rp0
-1685.00 (-100.00%)
Price Rp0

DVLA Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet established dividend payer.

3 Risks
1 Reward

PT Darya-Varia Laboratoria Tbk Key Details

Rp2.4t

Revenue

Rp1.1t

Cost of Revenue

Rp1.2t

Gross Profit

Rp1.1t

Other Expenses

Rp136.2b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
121.63
51.93%
5.79%
0%
View Full Analysis

About DVLA

Founded
1976
Employees
1351
CEO
Ian Martin Kloer
WebsiteView website
www.darya-varia.com

PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Consumer Health Products, Prescription Drugs, Export & Toll Manufacturing, and Services. The company offers consumer health products, including skin nutrition products under the Natur-E brand; respiratory products under the Decolgen, ALLERIN EXPECTORANT, Decolsin, NEOZEP, STOP COLD, SILEX, and HERBABLEND brands for nasal congestion, cough, and breathing issues caused by allergy; multivitamins under the Enervon-C, Enervon Active, Enervon Gold, and Supertin brands; vitamin C under the Vicee brand; supplement for kids with Zinc and vitamin C under the Imunped brand; Biogesic for various types of pain; Diatabs, a anti diarrhea product; and New Enzyplex to prevent indigestion. It also provides prescription products for various therapeutic areas, including cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women healthcare, antiparasit, vitamin and food supplements, anti fungal, plastic surgery, general surgery, burn, trauma wound, aesthetic medicine, somatik, ear healthcare, and central nerve systems. In addition, the company offers toll manufacturing services for soft gelatin capsules, as well as sterile injections and low volume solid products. It also exports its products. The company was founded in 1976 and is headquartered in Jakarta, Indonesia. PT Darya-Varia Laboratoria Tbk operates as a subsidiary of Blue Sphere Singapore Pte. Ltd.

Recent DVLA News & Updates

Recent updates

No updates

PT Darya-Varia Laboratoria Tbk Competitors